Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1

Mutation at the R132 residue of IDH1, frequently found in gliomas and acute myelogenous leukemia, creates a neo-enzyme that produces 2-hydroxyglutarate (2-HG) from α-ketoglutarate (α-KG). We sought to therapeutically exploit this neo-reaction in mutant IDH1 cells which requires α-KG derived from glu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Seltzer, Meghan J., Bennett, Bryson D., Joshi, Avadhut D., Gao, Ping, Thomas, Ajit G., Ferraris, Dana V., Tsukamoto, Takashi, Rojas, Camilo J., Slusher, Barbara S., Rabinowitz, Joshua D., Dang, Chi V., Riggins, Gregory J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058858/
https://ncbi.nlm.nih.gov/pubmed/21045145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1666
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller